drugset / Trial / NCT02707224

Clinical Trial to Compare the Pharmacokinetics of DP-R208

NCT02707224

Phase 1 Completed 40 enrolled Alvogen Korea
RandomizedCrossoverOpen-labelTreatment

Summary

A randomized, single-dose, open, crossover clinical trial to compare the pharmacokinetics of DP-R208 (Candesartan cilexetil and Rosuvastatin calcium fixed dose combinations) in comparison to each component administered alone in healthy male volunteers

Timeline

Start
2015-01
Primary completion
2015-06
Completion
2015-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Candesartan cilexetil Unknown
Subject DP-R208 Unknown
Subject Rosuvastatin Small molecule

Indications

No indication recorded.